SOVEREIGNTY & AUTONOMY

Localization of Advanced Plasma Fractionation Process; A Vital Step in the Country’s Pharmaceutical Self-Sufficiency

Date: July 29, 2026 | Read Time: 5 mins
Localization of Advanced Plasma Fractionation Process; A Vital Step in the Country’s Pharmaceutical Self-Sufficiency
Achieving technological independence in the human blood plasma fractionation chain is one of the country's strategic goals in the field of pharmaceutical biotechnology. In this scientific monograph, we review the achievements of nojin's R&D department in localizing advanced membrane separation methods.

Technical Challenges in Biomolecule Separation Process

Plasma is a biological fluid containing over hundreds of types of active proteins whose separation without destroying the 3D structure and denaturing the biomolecules requires precise control of temperature, pH, and ionic concentration. Traditional separation processes (Cohn method) based on ethanol precipitation, although effective, lack sufficient efficiency for the complete recovery of immunoglobulins and rare coagulation factors.

Realizing the stability of the supply chain of plasma-derived drugs in the country is beyond an economic goal; it is a national pharmaceutical security necessity in critical situations.

Fuzzy Ultrafiltration Technology in nojin Laboratories

The team of nojin researchers stationed at the National Institute of Genetic Engineering (Pajouhesh Blvd) has successfully implemented a fuzzy ultrafiltration system by optimizing multi-layer polymeric membranes. As a safe and cost-effective alternative, this system enables rapid concentration and dialysis of proteins without the need for destructive chemical additives.

Figure 1: Flow metric analysis of the plasma fractionation system on a semi-industrial scale.

Using this methodology, the final product of albumin and immunoglobulin reaches an extraordinary purity level of 98.5%, fully complying with USP and BP international pharmacopoeias, severely reducing the risk of secondary allergic reactions in special patients.

Related Research Findings

Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran
strategic-partnerships-en

Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran

Read Time: 3 mins September 18, 2026
Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards
rnd-production-en

Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards

Read Time: 5 mins September 18, 2026
Nojine Scientists Present Breakthrough Clinical Research at 25th International Congress of Pharmaceutical Biotechnology
events-conferences-en

Nojine Scientists Present Breakthrough Clinical Research at 25th International Congress of Pharmaceutical Biotechnology

Read Time: 4 mins September 18, 2026